Literature DB >> 14555985

Constitutive upregulation of hypoxia-inducible factor-1alpha mRNA occurring in highly metastatic lung carcinoma cells leads to vascular endothelial growth factor overexpression upon hypoxic exposure.

Nobuko Koshikawa1, Ayako Iyozumi, Max Gassmann, Keizo Takenaga.   

Abstract

Neoangiogenesis is crucial for tumor growth and metastasis and is regulated by various angiogenic factors including vascular endothelial growth factor (VEGF). However, little is known whether highly metastatic cells express higher level of VEGF in response to various stimuli, thereby increasing neoangiogenesis compared to low-metastatic cells. Here we report that hypoxia markedly induced the expression of VEGF mRNA in the cell lines with high-metastatic potential (A11 and D6 cells) compared to the cell lines with low-metastatic potential (P29 and P34 cells) established from Lewis lung carcinoma. A11 cells exhibited higher VEGF gene-promoter activity, produced a larger amount of VEGF and showed higher activity to induce neoangiogenesis than P29 cells. Although the degradation rate of VEGF mRNA under hypoxic conditions was similar in both cell lines, hypoxia-inducible factor-1alpha (HIF-1alpha) mRNA, but not HIF-1beta mRNA, was found to be constitutively upregulated in A11 cells compared to P29 cells. Accordingly, the level of HIF-1alpha protein in response to hypoxia was higher in A11 cells than in P29 cells. Upregulation of HIF-1alpha mRNA was also observed in D6 cells but not in P34 cells. Thus, the high-metastatic cells produced a larger amount of VEGF under hypoxic conditions through constitutive HIF-1alpha mRNA upregulation compared to the low-metastatic cells, thereby leading to extensive neoangiogenesis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14555985     DOI: 10.1038/sj.onc.1206765

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  20 in total

1.  Adaptive evolution of heparanase in hypoxia-tolerant Spalax: gene cloning and identification of a unique splice variant.

Authors:  Nicola J Nasser; Eviatar Nevo; Itay Shafat; Neta Ilan; Israel Vlodavsky; Aaron Avivi
Journal:  Proc Natl Acad Sci U S A       Date:  2005-10-04       Impact factor: 11.205

Review 2.  The lymph node microenvironment and its role in the progression of metastatic cancer.

Authors:  Ethel R Pereira; Dennis Jones; Keehoon Jung; Timothy P Padera
Journal:  Semin Cell Dev Biol       Date:  2015-01-22       Impact factor: 7.727

Review 3.  Regulation of metastasis; mitochondrial DNA mutations have appeared on stage.

Authors:  Kaori Ishikawa; Hirotake Imanishi; Keizo Takenaga; Jun-Ichi Hayashi
Journal:  J Bioenerg Biomembr       Date:  2012-12       Impact factor: 2.945

4.  Latent Kaposi's sarcoma-associated herpesvirus infection of endothelial cells activates hypoxia-induced factors.

Authors:  Patrick A Carroll; Heidi L Kenerson; Raymond S Yeung; Michael Lagunoff
Journal:  J Virol       Date:  2006-09-06       Impact factor: 5.103

Review 5.  HIF, hypoxia and the role of angiogenesis in non-small cell lung cancer.

Authors:  Autumn L Jackson; Bing Zhou; William Y Kim
Journal:  Expert Opin Ther Targets       Date:  2010-10       Impact factor: 6.902

6.  Modeling the inhibition of breast cancer growth by GM-CSF.

Authors:  Barbara Szomolay; Tim D Eubank; Ryan D Roberts; Clay B Marsh; Avner Friedman
Journal:  J Theor Biol       Date:  2012-03-28       Impact factor: 2.691

7.  Hypoxic lung cancer-secreted exosomal miR-23a increased angiogenesis and vascular permeability by targeting prolyl hydroxylase and tight junction protein ZO-1.

Authors:  Y-L Hsu; J-Y Hung; W-A Chang; Y-S Lin; Y-C Pan; P-H Tsai; C-Y Wu; P-L Kuo
Journal:  Oncogene       Date:  2017-04-24       Impact factor: 9.867

8.  The clinicopathological significance of tissue levels of hypoxia-inducible factor-1alpha and vascular endothelial growth factor in gastric cancer.

Authors:  Seong-Eun Kim; Ki-Nam Shim; Sung-Ae Jung; Kwon Yoo; Joo Ho Lee
Journal:  Gut Liver       Date:  2009-06-30       Impact factor: 4.519

9.  Hypoxia inducible factors-mediated inhibition of cancer by GM-CSF: a mathematical model.

Authors:  Duan Chen; Julie M Roda; Clay B Marsh; Timothy D Eubank; Avner Friedman
Journal:  Bull Math Biol       Date:  2012-10-17       Impact factor: 1.758

10.  Human placental hypoxia-inducible factor-1alpha expression correlates with clinical outcomes in chronic hypoxia in vivo.

Authors:  Stacy Zamudio; Yuanhong Wu; Francesca Ietta; Alessandro Rolfo; Ashley Cross; Timothy Wheeler; Martin Post; Nicholas P Illsley; Isabella Caniggia
Journal:  Am J Pathol       Date:  2007-06       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.